Email ID
Password
Sign me in automatically next time
Scrip Regulatory Affairs
AdvaMed warns of gaps in product access under CMS bidding scheme
20 July 2010
Bernard Murphy

US medtech industry association AdvaMed has voiced concerns over the competitive acquisition programme initiated by the Centers for Medicare and Medicaid Services. The association claims that the programme could limit the accessibility of products1.

"We are concerned that, as the number of suppliers of durable medical equipment (DME) decreases, many elderly and disabled patients will experience disruptions in care as they navigate the new system to find a new supplier or the specific medical items they need," said AdvaMed's executive vice president for payment and healthcare delivery policy, Ann-Marie Lynch...

Please login to read the full article.
 
 
 
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
   
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36